These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10549908)

  • 1. Effect of pilsicainide, a pure sodium channel blocker, on spiral waves during atrial fibrillation: theoretical analysis by numerical simulation.
    Namba T; Ashihara T; Nakazawa K; Ohe T
    J Electrocardiol; 1999 Oct; 32(4):321-34. PubMed ID: 10549908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of refractory periods and conduction velocity during atrial fibrillation using atrial capture in dogs: direct assessment of the wavelength and its modulation by a sodium channel blocker, pilsicainide.
    Shinagawa K; Mitamura H; Takeshita A; Sato T; Kanki H; Takatsuki S; Ogawa S
    J Am Coll Cardiol; 2000 Jan; 35(1):246-53. PubMed ID: 10636287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widening of the excitable gap and enlargement of the core of reentry during atrial fibrillation with a pure sodium channel blocker in canine atria.
    Kawase A; Ikeda T; Nakazawa K; Ashihara T; Namba T; Kubota T; Sugi K; Hirai H
    Circulation; 2003 Feb; 107(6):905-10. PubMed ID: 12591763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postrepolarization refractoriness as a potential anti-atrial fibrillation mechanism of pilsicainide, a pure sodium channel blocker with slow recovery kinetics.
    Kanki H; Mitamura H; Takatsuki S; Sueyoshi K; Shinagawa K; Sato T; Ogawa S
    Cardiovasc Drugs Ther; 1998 Oct; 12(5):475-82. PubMed ID: 9926279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pilsicainide and propafenone on vagally induced atrial fibrillation: role of suppressant effect in conductivity.
    Iwasa A; Okumura K; Tabuchi T; Tsuchiya T; Tsunoda R; Matsunaga T; Tayama S; Yasue H
    Eur J Pharmacol; 1998 Aug; 356(1):31-40. PubMed ID: 9761421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electropharmacologic effects of pilsicainide, a pure sodium channel blocker, on the remodeled atrium subjected to chronic rapid pacing.
    Sato T; Mitamura H; Kurita Y; Takeshita A; Shinagawa K; Miyoshi S; Kanki H; Hara M; Ogawa S
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):812-20. PubMed ID: 11707684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainide.
    Kanemoto M; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kakugawa H; Kametani R; Inoue N; Sawa A; Matsuzaki M
    Cardiovasc Drugs Ther; 2004 Jul; 18(4):295-303. PubMed ID: 15367827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sodium channel blocker, pilsicainide, produces atrial post-repolarization refractoriness through the reduction of sodium channel availability.
    Fukuda K; Watanabe J; Yagi T; Wakayama Y; Nakano M; Kondo M; Kumagai K; Miura M; Shirato K; Shimokawa H
    Tohoku J Exp Med; 2011 Sep; 225(1):35-42. PubMed ID: 21869589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pilsicainide on the atrial fibrillation threshold in guinea pig atria. A comparative study with disopyramide, lidocaine and flecainide.
    Inoue M; Inoue D; Ishibashi K; Sakai R; Omori I; Yamahara Y; Asayama J; Nakagawa M
    Jpn Heart J; 1993 May; 34(3):301-12. PubMed ID: 8411636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome.
    Morita H; Morita ST; Nagase S; Banba K; Nishii N; Tani Y; Watanabe A; Nakamura K; Kusano KF; Emori T; Matsubara H; Hina K; Kita T; Ohe T
    J Am Coll Cardiol; 2003 Nov; 42(9):1624-31. PubMed ID: 14607450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilsicainide for atrial fibrillation.
    Kumagai K; Nakashima H; Tojo H; Yasuda T; Noguchi H; Matsumoto N; Ogawa M; Saku K
    Drugs; 2006; 66(16):2067-73. PubMed ID: 17112301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the NA+ channel blocker pilsicainide on the electrophysiologic properties of pulmonary veins in patients with atrial fibrillation.
    Kumagai K; Tojo H; Noguchi H; Yasuda T; Ogawa M; Nakashima H; Zhang B; Saku K
    J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1396-401. PubMed ID: 15610286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of sinus pause due to the proarrhythmia of pilsicainide.
    Toeda T; Susa R; Saigawa T; Abe T; Yamaguchi Y; Fuse K; Murooka H
    Jpn Heart J; 2000 May; 41(3):405-10. PubMed ID: 10987357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of the preventive effect of pilsicainide on atrial fibrillation originating from the pulmonary vein.
    Hirose M; Ohkubo Y; Takano M; Hamazaki M; Sekido T; Yamada M
    Circ J; 2007 Nov; 71(11):1805-14. PubMed ID: 17965507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pilsicainide on dominant frequency in the right and left atria and pulmonary veins during atrial fibrillation: association with its atrial fibrillation terminating effect.
    Horiuchi D; Iwasa A; Sasaki K; Owada S; Kimura M; Sasaki S; Okumura K
    Eur J Pharmacol; 2009 Apr; 608(1-3):54-61. PubMed ID: 19268659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological effects of an anti-influenza drug oseltamivir on the guinea-pig atrium: comparison with those of pilsicainide.
    Takahara A; Suzuki S; Hagiwara M; Nozaki S; Sugiyama A
    Biol Pharm Bull; 2013; 36(10):1650-2. PubMed ID: 24088258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sodium channel blocker, pilsicainide hydrochloride, on net inward current of atrial myocytes in thyroid hormone toxicosis rats.
    Yamakawa M; Sunagawa M; Shimabukuro M; Higa N; Takasu N; Kosugi T
    Thyroid; 2005 Jul; 15(7):653-9. PubMed ID: 16053380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pilsicainide on atrial electrophysiologic properties in the canine rapid atrial stimulation model.
    Kojima J; Niwano S; Moriguchi M; Ikeda K; Inuo K; Saito J; Izumi T
    Circ J; 2003 Apr; 67(4):340-6. PubMed ID: 12655166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation.
    Burashnikov A; Belardinelli L; Antzelevitch C
    Heart Rhythm; 2015 Apr; 12(4):836-44. PubMed ID: 25546810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
    Aguilar M; Xiong F; Qi XY; Comtois P; Nattel S
    Circulation; 2015 Dec; 132(23):2203-11. PubMed ID: 26499964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.